Project Grant F31DC023096

Award Date 9/30/25
Completion Date 8/21/27
Dollars Obligated $105K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal grant program "Research Related to Deafness and Communication Disorders" (CFDA 93.173), provides $633,694 to North Carolina State University to develop a non-invasive treatment strategy using a vocal fold lamina propria extract (VFLPX) to address vocal fold scarring and laryngotracheal injuries. The key objectives are to: 1) conduct detailed investigations...
This $142,074 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under CFDA Program 93.173 "Research Related to Deafness and Communication Disorders", supports research to determine the impact of microbial imbalance (dysbiosis) and immune activation on the formation of scar tissue in the larynx (glottic stenosis) following acute laryngeal injury. The 5-year project at the University of Wisconsin-Madison aims to: 1) characterize the...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $631,703 Project Grant (CFDA 93.173) to Washington University to investigate the use of muscle progenitor cells for treating vocal fold paralysis. The grant, which runs from March 1, 2025 to February 28, 2030, will fund experiments in a canine model to evaluate the efficacy of implanting muscle progenitor cells to increase nerve recovery and muscle strength in cases of vocal fold paralysis, a condition...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $110,266 to the University of Wisconsin-Madison to conduct research on disruption of vocal fold epithelial homeostasis by injury and papillomavirus (PV) infection. The overarching goal is to better understand how PV establishes vocal fold infections that lead to recurrent respiratory...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal grant program "Research Related to Deafness and Communication Disorders" (CFDA 93.173), will fund the development of noninvasive aerodynamic assessments for evaluating voice disorders in children aged 4-17 years. The $405,748 award to the University of Wisconsin System will support research to optimize reliable methods for measuring aerodynamic parameters in...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $277,810 to Femtovox Inc. to develop an image-guided automated ultrafast laser device for laryngeal (voice box) surgery. The key objectives are to demonstrate the superior ability of ultrafast lasers to minimize collateral damage in laryngeal tissue, characterize laser-based...
This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA Program 93.173 - Research Related to Deafness and Communication Disorders will fund a $450,000 study at Baylor University to investigate the impact of omega-3 fatty acid supplementation on vocal fold inflammation and recovery in female professional voice users. The 3-year study aims to 1) determine the feasibility and impact of an omega-3 supplement intervention on recovery...
The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded a $947,128 Project Grant (CFDA 93.173) to Emory University to conduct research on optimizing voice therapy for individuals with voice disorders. The key objectives are to compare outcomes between non-hierarchical and hierarchical delivery methods of conversation training therapy (CTT), and to investigate the effects of the clear speech component on voice quality and outcomes. This research aims to enhance...
The National Institute on Deafness and Other Communication Disorders (NIDCD), part of the National Institutes of Health (NIH), awarded Ripple LLC a $382,366 Project Grant (CFDA 93.173 - Research Related to Deafness and Communication Disorders) to develop a closed-loop laryngeal functional electrical stimulation (FES) system. This novel system aims to reanimate vocal fold closure (adduction) to treat unilateral vocal fold paralysis, a common neurogenic voice disorder that can significantly impact...
This federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the CFDA 93.173 "Research Related to Deafness and Communication Disorders" program, supports research to identify the progenitor cell population that maintains the circumvallate papilla (CVP) and von Ebner's gland (VEG) epithelium. The key objectives are to: Use genetic barcoding and single-cell RNA sequencing to determine the lineage relationships of the SOX9+...

This federal Project Grant award of $104,512, provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under CFDA program 93.173 "Research Related to Deafness and Communication Disorders", aims to develop novel treatments for vocal fold scarring.

The research project, conducted by the University of Wisconsin-Madison, will use CRISPR/Cas-9 gene editing technology to target specific signaling pathways in vocal fold fibroblasts with the goal of preventing their differentiation into scar-forming myofibroblasts. The proposed in vitro studies will assess the effects of gene editing on fibroblast proliferation, differentiation, and extracellular matrix production, with the objective of identifying new therapeutic targets to mitigate vocal fold scarring and improve voice quality for affected patients. The award period runs from September 30, 2025 to August 21, 2027.

Generated 8/5/25, 5:29 AM